Form 4: Cigna Group Executive Brian C. Evanko Executes Stock Option and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Brian C. Evanko, EVP, Chief Financial Officer and President & CEO, Cigna Healthcare, exercised stock options and sold shares of Cigna Group (CI) common stock on June 24 and 25, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On June 24, 2024, Brian C. Evanko exercised employee stock options to acquire 4,795 shares of Cigna Group common stock at an exercise price of $120.895 per share.
- Simultaneously, Mr. Evanko sold 4,795 shares at a weighted average price of $345.0058, with prices ranging from $345.00 to $345.07.
- On June 25, 2024, Mr. Evanko exercised additional employee stock options to acquire 1,011 shares of Cigna Group common stock at $120.895 per share.
- Following these transactions, Mr. Evanko directly owns 39,923 shares of Cigna Group common stock and indirectly owns 883.1588 shares through a 401(k) plan.
- The transactions were executed under a Rule 10b5-1 trading plan adopted on February 15, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The transactions are part of a pre-planned trading plan, indicating routine activity rather than a significant shift in sentiment.
Positives
- The use of a 10b5-1 trading plan suggests a pre-planned and orderly approach to stock transactions, potentially mitigating concerns about insider trading.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, although the use of a 10b5-1 plan can help alleviate these concerns.
Future Outlook
The document does not contain specific forward-looking statements beyond the ongoing execution of the 10b5-1 trading plan.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies, and are closely monitored by investors for insights into management's perspective on the company's value and prospects.
Comparison to Industry Standards
- Executive compensation practices, including stock options and trading plans, are common across the healthcare industry.
- Companies like UnitedHealth Group (UNH) and Anthem (now Elevance Health) also utilize stock-based compensation and 10b5-1 trading plans for their executives.
- The specific details of these plans, such as vesting schedules and exercise prices, vary from company to company.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 2015-02-25 | Date the employee stock option was granted. |
| 2016-02-25 | First vesting date of the employee stock option. |
| 2024-02-15 | Date the reporting person adopted the Rule 10b5-1 trading plan. |
| 2024-06-24 | Date of stock option exercise and sale of shares. |
| 2024-06-25 | Date of stock option exercise. |
| 2025-02-25 | Expiration date of the employee stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.